Assessing the Burden of Notifiable Infectious Diseases in China,2010-2020: A Comparison of National Surveillance Data and Global Estimates

Abstract

Background: notifiable infectious diseases (NIDs) pose a notable public health challenge globally,and understanding their burden‍ is crucial for effective prevention and control. This study aimed to quantify‍ the disease burden of 14 NIDs in China from 2010 to 2020 using national surveillance data, and to compare⁣ these findings with estimates ‍from the Global burden of Disease (GBD) 2021 study.

Methods: Disability-Adjusted Life Years (DALYs) were calculated⁢ for 14 NIDs using data from china’s national surveillance system. DALY calculations incorporated uncertainty through triangular distributions for relevant ‍parameters. ‍Trends in disease burden were visualized using line, bubble, pie charts, and heatmaps. disease rankings were established based on 11-year average DALYs, and discrepancies between national data and GBD 2021 estimates⁢ were quantified. A extensive timeline of prevention and control policies was constructed⁢ through ⁢a ⁣review of official government websites and databases.

Results: ⁣ ⁣ This analysis reveals the evolving landscape of infectious disease burden in China, highlighting key diseases⁢ and potential differences in prioritization between national ⁤surveillance and global ‍modeling efforts. The⁣ study⁢ identifies⁢ critical prevention and control milestones achieved during the study period.

Conclusions: A robust national surveillance ⁢system is essential for accurately assessing disease burden and informing public⁤ health strategies. Comparison with global estimates provides valuable insights for refining national priorities and strengthening‍ infectious disease control efforts in China.

Introduction

Infectious diseases remain a leading cause of morbidity and mortality worldwide, particularly in densely populated countries like⁣ China.effective public ⁢health interventions require a comprehensive understanding of the disease⁣ burden, including ⁢both incidence and the associated disability. Notifiable infectious diseases (NIDs) – those legally required to be reported to public health authorities – ‍represent a critical component of this ‍understanding.china has a well-established national surveillance system for NIDs, providing valuable ⁣data for monitoring trends and⁣ evaluating the impact of control measures. However, interpreting this data and comparing it with global ‍estimates requires careful consideration of methodological differences and potential ‍biases.

The Global Burden of Disease (GBD) study,⁢ a comprehensive effort to quantify⁢ the health loss from diseases, injuries, and risk factors, provides valuable estimates of disease burden at a global and national level. while⁢ GBD estimates are based on a standardized methodology and‍ incorporate data from ⁤multiple sources, they rely heavily on modeling and may differ ⁤from ⁣national surveillance data due to variations in ⁣data availability, reporting practices, and modeling⁢ assumptions.

This study aims to quantify the burden of 14⁤ NIDs in china from 2010 to 2020 using‍ national ⁤surveillance data, and to compare these findings with⁣ estimates from the⁣ GBD 2021 study. ⁣By identifying discrepancies and understanding the underlying ⁣reasons for these⁢ differences, we can contribute to a more accurate assessment of the infectious ⁤disease landscape in China and inform ⁢the development of more effective prevention and control strategies. This research directly addresses ⁣a critical need for accurate epidemiological data‍ to⁢ support evidence-based ⁣public health decision-making, aligning with the goals of the Healthy China 2030⁢ initiative.

Methods

Data ⁤sources

National surveillance data on 14 NIDs in China, covering the ⁤period ⁣2010-2020, were obtained from the China Data System for Disease Control and Prevention (CISDC). The 14 nids included in this study were⁣ selected based on their notifiable status and‍ public health importance. These diseases represent a range of transmission routes and clinical presentations, providing a comprehensive overview of the infectious disease landscape.

DALY Calculation

Disability-Adjusted Life Years ⁣(DALYs) were calculated to quantify the burden of each⁤ NID. DALYs combine years of life lost (YLLs) due to premature mortality and years lived with disability⁤ (YLDs) due to non-fatal health outcomes. The calculation ‍followed established⁤ methods [20], utilizing age-weighting and discounting to‍ reflect the value of a year of life lived at different ages and times.

In the simulation process, triangular distributions were applied⁢ to‍ the relevant parameters to account for the inherent uncertainty in ⁢the data. This approach, a robust method for handling parameter uncertainty, provides a more realistic representation of the potential range of DALY estimates.

Visualization of DALY ⁢Trends

DALYs for the 14 NIDs were visualized using various graphical methods. Line charts were used to illustrate temporal changes in the overall disease burden, while bubble⁣ charts highlighted the relative contributions of each disease within the three‍ major categories (respiratory, intestinal, and vector-borne diseases